desulfated gastrin-17 (Human) [2873]



desulfated gastrin-17 (Human)


SMILES CSCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@@H]1CCC(=O)N1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O
InChIKey GKDWRERMBNGKCZ-RNXBIMIWSA-N
Sequence XGPWLEEEEEAYGWMDF
HELM PEPTIDE1{[Glp].G.P.W.L.E.E.E.E.E.A.Y.G.W.M.D.F.[am]}$$$$

Chemical Properties

Hydrogen bond acceptors 26
Hydrogen bond donors 26
Rotatable bonds 62
Log P -3.467
Molecular weight (Da) 2096.8
Stereochemistry info unspecified


Bioactivities

Receptor Activity Source
Protein Gene Species Family Class Type Min Avg Max Database
Receptor Activity Source
Protein Gene Species Family Class Type Min Avg Max Database

desulfated gastrin-17 (Human)


Drug properties

Molecular type Peptide
Physiological/Surrogate Endogenous
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0


Compound is not listed as a drug.